Sauvage, D.; Bosseler, M.; Viry, E.; Kanli, G.; Oudin, A.; Berchem, G.; Keunen, O.; Janji, B.
The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model. Cells 2022, 11, 2783.
https://doi.org/10.3390/cells11182783
AMA Style
Sauvage D, Bosseler M, Viry E, Kanli G, Oudin A, Berchem G, Keunen O, Janji B.
The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model. Cells. 2022; 11(18):2783.
https://doi.org/10.3390/cells11182783
Chicago/Turabian Style
Sauvage, Delphine, Manon Bosseler, Elodie Viry, Georgia Kanli, Anais Oudin, Guy Berchem, Olivier Keunen, and Bassam Janji.
2022. "The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model" Cells 11, no. 18: 2783.
https://doi.org/10.3390/cells11182783
APA Style
Sauvage, D., Bosseler, M., Viry, E., Kanli, G., Oudin, A., Berchem, G., Keunen, O., & Janji, B.
(2022). The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model. Cells, 11(18), 2783.
https://doi.org/10.3390/cells11182783